Bing

SEARCH HISTORY

Stem cell developer Athersys (NASDAQ:ATHX) has secured $9 million in a private placement with an unidentified investor. Cleveland-based Athersys said it would issue about 4.3 million shares of common stock and an equal number of warrants to purchase …
MedCity News · ByBrandon Glenn · 3/9/2012
(RTTNews) - Athersys Inc. (ATHX) suffered a blow on Friday with the stock price dropping to a new 52-week low, on news that the primary and secondary endpoints of the company's phase II study of MultiStem cell therapy for treatment of ischemic stroke did ...
AD HOC News · 4/20/2015
Oct 23, 2013 (ACCESSWIRE via COMTEX) -- Athersys Inc. ATHX, -0.79% a clinical stage biotechnology company ... two-year agreement with the right to sell up to $25 million in common stock under certain conditions over a two-year period.
Market Watch · 10/23/2013
Obviously, we’re seeing all-time stock market highs in the Dow Jones averages ... Another one is Athersys Inc. (ATHX:NASDAQ), which is in a remarkable position in that it has a partnership with Pfizer Inc. (PFE:NYSE) for inflammatory bowel disease ...
Trefis · 4/11/2013
March 12, 2015 16:05 ET | Source: Athersys, Inc. CLEVELAND, March 12, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial ... reagent costs and stock-based compensation were partially offset by lower sponsored …
GlobeNewswire · 3/12/2015
The company, which has never been profitable, watched its stock jump in early trading. The stock, ATHX, closed at $2.40 a share Monday up from $1 at the closing bell Friday. Still, Wall Street numbers do not reflect the real value of biopharmaceutical ...
Cleveland Plain Dealer · BySarah Jane Tribble · 12/21/2009
In the news of Tuesday was Stem Cells, Inc. (STEM), listed on The Wall Street Journal as a “U.S. Hot Stock” after announcing that 12 ... a hotter stem cell play in 2013 than Athersys, Inc. (ATHX). Headquartered in Ohio, just down the street from ...
Finance Yahoo · 2/15/2013
Athersys (ATHX) has benefited from some upbeat buzz about its positive ... That sounded pretty good to investors, who drove the stock up 18 percent on the news. Late last year Pfizer inked a $111 million deal to license rights to develop Athersys' cell ...
Fierce Biotech · ByJohn Carroll · 7/29/2010
CLEVELAND, OH, USA and TOKYO, Japan I March 2, 2015 I Athersys, Inc. (NASDAQ: ATHX) and Chugai Pharmaceutical Co., Ltd. (Tokyo Stock Exchange: 4519) have announced a partnership and license agreement to exclusively develop and …
PipelineReview.com · 3/2/2015
On the oil front, CNQ reported better than expected cash flow, raised its dividend and the stock is higher in the pre-market ... drug development), Cyberonics (CYBX), Athersys (ATHX) and Navidea (NAVB). We also have earnings to watch including Costco ...
Business News Network · 3/5/2015